Factors Influencing the Local Failure Rate of Radiofrequency Ablation of Colorectal Liver Metastases

BackgroundThe prognosis of patients with colorectal cancer is poor, especially when there is distant metastatic disease. Local ablation of tumor by radiofrequency ablation (RFA) has emerged as a safe and effective new treatment modality, but its long-term efficacy may be hindered by renewed local tumor growth at the site of RFA. The objectives of this study were to identify risk factors for local RFA failure and to define exclusion criteria for RFA treatment of colorectal liver metastases.MethodsA total of 199 lesions in 87 patients were ablated with RFA. Factors influencing local failure rates were identified and compared with data from the literature.ResultsThe local failure rate was 47.2%, and the average time to local disease progression was 6.5 months. Factors that significantly correlated with increased failure rates were metachronous occurrence of liver metastases, large mean lesion size, and central tumor location.ConclusionsBecause accurate electrode placement is pivotal in achieving adequate tumor necrosis, RFA should not be performed percutaneously when electrode placement is impaired. We suggest that lesions >5 cm and lesions located near great vessels or adjacent organs should be treated with open RFA, thus allowing vascular inflow occlusion and complete mobilization of the liver. Lesions that are difficult to reach by electrodes should be approached by an open procedure.

[1]  M. C. Jansen,et al.  Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver , 2003, The British journal of surgery.

[2]  James Sayre,et al.  Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. , 2003, Journal of vascular and interventional radiology : JVIR.

[3]  S. Mulier,et al.  Complications of radiofrequency coagulation of liver tumours , 2002, The British journal of surgery.

[4]  N. Habib,et al.  Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. , 1999, American journal of surgery.

[5]  W. Silen,et al.  Hepatic resection for metastases from colorectal carcinoma is of dubious value. , 1989, Archives of surgery.

[6]  W. Enker,et al.  Liver resection for colorectal metastases. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Sergi Ganau,et al.  Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma , 2001, Hepatology.

[8]  E. Grundmann,et al.  Haematogenous metastastic patterns in colonic carcinoma: An analysis of 1541 necropsies , 1986 .

[9]  Daan Brandenbarg.  The National. , 1892 .

[10]  Thomas J Vogl,et al.  Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. , 2003, Radiology.

[11]  A. Alavi,et al.  FDG Positron Emission Tomography in the Surveillance of Hepatic Tumors Treated with Radiofrequency Ablation , 2003, Clinical nuclear medicine.

[12]  I Taylor,et al.  Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases , 2003, The British journal of surgery.

[13]  T. Pawlik,et al.  Combined Resection and Radiofrequency Ablation for Advanced Hepatic Malignancies: Results in 172 Patients , 2003, Annals of Surgical Oncology.

[14]  G. Gazelle,et al.  Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection , 2003, Cancer.

[15]  Steven A. Curley,et al.  Early and Late Complications After Radiofrequency Ablation of Malignant Liver Tumors in 608 Patients , 2004 .

[16]  Luigi Solbiati,et al.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. , 2003, Radiology.

[17]  L. J. Wei,et al.  The Robust Inference for the Cox Proportional Hazards Model , 1989 .

[18]  J. Welch,et al.  The clinical correlation of an autopsy study of recurrent colorectal cancer. , 1979, Annals of surgery.

[19]  D. Winchester,et al.  The National Cancer Data Base report on colon cancer , 1996, Cancer.

[20]  Junji Machi,et al.  Ultrasound-guided radiofrequency thermal ablation of liver tumors: Percutaneous, laparoscopic, and open surgical approaches , 2001, Journal of Gastrointestinal Surgery.

[21]  S. Curley,et al.  Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. , 2003, Surgical oncology clinics of North America.

[22]  H. Nisenbaum,et al.  Percutaneous radiofrequency ablation of liver tumors with the LeVeen probe: is roll-off predictive of response? , 2001, Journal of vascular and interventional radiology : JVIR.

[23]  E F Halpern,et al.  Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. , 2001, Radiology.

[24]  Mathew Chung,et al.  Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications , 2000, Annals of Surgical Oncology.

[25]  Kenneth Hess,et al.  Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases , 2004, Annals of surgery.

[26]  W. Lees,et al.  Radiofrequency ablation extends the scope of surgery in colorectal liver metastases. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  S. Goldman,et al.  [F‐18] Fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases , 2003, Journal of surgical oncology.

[28]  E. Sjolie,et al.  3D ultrasound-based navigation for radiofrequency thermal ablation in the treatment of liver malignancies , 2003, Surgical Endoscopy And Other Interventional Techniques.

[29]  R Fiocca,et al.  Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. , 1997, Radiology.

[30]  A. B. Barnes,et al.  Comparison of Histologic and Colposcopic Findings in DES-Exposed Females , 1978, Obstetrics and gynecology.

[31]  L. Ellis,et al.  Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies: Results in 123 Patients , 1999 .

[32]  J. McCall,et al.  The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned. , 2002, The New Zealand medical journal.

[33]  F. Marshall,et al.  The national cancer data base , 1997, Cancer.

[34]  Dirk Stippel,et al.  Experimental evaluation of accuracy of radiofrequency ablation using conventional ultrasound or a third-dimension navigation tool , 2002, Langenbeck's Archives of Surgery.

[35]  T. de Baère,et al.  Adverse events during radiofrequency treatment of 582 hepatic tumors. , 2003, AJR. American journal of roentgenology.

[36]  D L Morton,et al.  Radiofrequency ablation: a minimally invasive technique with multiple applications. , 1999, The cancer journal from Scientific American.